Abemaciclib 150 MG

DRUG2 trials

Sponsors

University of Michigan Rogel Cancer Center, Forward Pharmaceuticals Co., Ltd.

Conditions

Breast Cancer Stage IBreast Cancer Stage IIER+ Breast CancerLocally Advanced Breast Cancer (LABC)Metastatic Breast CancerProstate Cancer

Phase 1

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

RecruitingNCT07002177

Forward Pharmaceuticals Co., Ltd.Breast Cancer Stage I, Breast Cancer Stage II, ER+ Breast Cancer +2

Start: 2025-06-01End: 2028-11-01Target: 196Updated: 2026-01-07

Phase 2

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

WithdrawnNCT04272645

University of Michigan Rogel Cancer CenterProstate Cancer

Start: 2020-10-31End: 2022-10-31Updated: 2020-07-15